释放俄歇电子放射性药物治疗的潜力
俄歇电子(AE)放射性药物治疗(RPT)对肿瘤小病灶可能具有与α粒子相同的疗效且正常组织毒性风险更低,但其潜力尚未实现,临床试验评估的药物极少且尚无药物进入常规治疗。应国际原子能机构2022年技术会议倡议,本综述基于领域专家讨论呈现AE RPT现状,采用评分系统说明开发障碍并列出研究较充分和新出现的AE发射放射性核素,基于AE数量及其他发射、物理半衰期、放射性核素生产、放射化学方法、剂量学和载体可及性提出建议。
要点
- AE RPT对肿瘤小病灶可能具有与α粒子相同的疗效,正常组织毒性风险更低。
- AE RPT的潜力尚未实现,临床试验评估的药物极少,尚无药物进入常规治疗。
- 综述基于专家讨论提出建议,以增强和影响未来AE RPT研究。
核心结论
- AE RPT可能对肿瘤小病灶具有与α粒子相同的疗效且正常组织毒性风险更低,但其前景尚未实现,临床试验评估的药物极少且尚无药物进入常规治疗。
研究设计与样本
- 应国际原子能机构2022年「俄歇电子发射体用于放射性药物开发技术会议」倡议,本综述基于领域专家讨论呈现AE RPT现状。
主要发现
- 关于AE发射体用于RPT的知识已积累数十年,对低能AE密集簇射所致生物学效应强度已有较多了解。
- 由于射程短,AE将其大部分能量沉积在衰变位点紧邻区域。
- AE RPT的潜力尚未实现,临床试验评估的药物极少,尚无药物进入常规治疗。
- 综述采用评分系统说明AE RPT开发中的障碍,并列出精选的研究较充分和新出现的AE发射放射性核素。
关键数值与推荐
- 基于AE数量及其他发射、物理半衰期、放射性核素生产、放射化学方法、剂量学和载体可及性提出建议,以增强和影响未来AE RPT研究。
局限性
- AE RPT的潜力尚未实现,临床试验评估的药物极少且尚无药物进入常规治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Auger electron (AE) radiopharmaceutical therapy (RPT) may have the same therapeutic efficacy as α-particles for oncologic small disease, with lower risks of normal-tissue toxicity. The seeds of using AE emitters for RPT were planted several decades ago. Much knowledge has been gathered about the potency of the biologic effects caused by the intense shower of these low-energy AEs. Given their short range, AEs deposit much of their energy in the immediate vicinity of their site of decay. However, the promise of AE RPT has not yet been realized, with few agents evaluated in clinical trials and none becoming part of routine treatment so far. Instigated by the 2022 "Technical Meeting on Auger Electron Emitters for Radiopharmaceutical Developments" at the International Atomic Energy Agency, this review presents the current status of AE RPT based on the discussions by experts in the field. A scoring system was applied to illustrate hurdles in the development of AE RPT, and we present a selected list of well-studied and emerging AE-emitting radionuclides. Based on the number of AEs and other emissions, physical half-life, radionuclide production, radiochemical approaches, dosimetry, and vector availability, recommendations are put forward to enhance and impact future efforts in AE RPT research.
引用
- Bolcaen J, Gizawy MA, Terry SYA, et al. Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy. J Nucl Med. 2023. PMID: 37591544. doi:10.2967/jnumed.122.265039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。